PLUS1
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Ip Group Plc | LSE:IPO | London | Ordinary Share | GB00B128J450 | ORD 2P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.30 | -2.8% | 79.90 | 79.50 | 80.00 | 80.70 | 78.60 | 80.70 | 1,172,053 | 16:35:12 |
| Industry Sector | Turnover (m) | Profit (m) | EPS - Basic | PE Ratio | Market Cap (m) |
|---|---|---|---|---|---|
| General Financial | 0.0 | -78.8 | -7.1 | - | 849 |
Ip (IPO) News Headlines
Ip News
| Date | Time | Source | Headline |
|---|---|---|---|
| 21/10/2020 | 06:00 | RNSNON | IP Group PLC Investor webinar |
| 13/10/2020 | 08:58 | ALNC |  IP Group's Oxford Nanopore Raises New Cash Amid Virus Test Progress |
| 13/10/2020 | 06:00 | RNSNON | IP Group PLC Oxford Nanopore funding round and contract win |
| 09/10/2020 | 09:37 | ALNC | IP Group Notes CE Mark For Oxford Nanopore's LamPORE Covid-19 Test |
| 09/10/2020 | 08:46 | UKREG | IP Group PLC Oxford Nanopore's LamPORE test gains CE-IVD mark |
| 07/10/2020 | 07:55 | ALNC | TOP NEWS: IP Group Notes Roche's Enterprise Therapeutics Program Buy |
| 07/10/2020 | 07:36 | DJN | IP Group Investee Sells Developing Drug Portfolio for GBP75 Million |
| 07/10/2020 | 06:00 | UKREG | IP Group PLC Enterprise Therapeutics' program acquired by Roche |
| 23/9/2020 | 12:40 | UKREG | DeepMatter Group PLC Holding(s) in Company |
| 15/9/2020 | 11:07 | UKREG | IP Group PLC Second Price Monitoring Extn |
1 Year Ip Chart |
Intraday Ip Chart |
